Of note, teratoma-associated MBT are characterized by an immunohistochemical expression profile similar to mucinous neoplasms of the lower gastrointestinal tract, with diffuse expression of cytokeratin 20 and CDX2 and absence of cytokeratin 7 [63, 89, 90]. This evidence concerns the gene CDX2 and teratoma.